AP

Atesh Pandurang Bhange

Active Director Director DIN 09649193
DIN 09649193 First appointment Jun 2022 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Atesh Pandurang Bhange

Data last updated:

Atesh Pandurang Bhange is a Director at Dellchem Healthcare Private Limited (since 2022). The company operates in Trading.

DIN 09649193
Primary Designation Director
Industry Trading
First Appointment 23 Jun 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dellchem Healthcare Private Limited U51909MH2022PTC385223
Director23 Jun 20222022Active

Board colleagues of Atesh Pandurang Bhange

NameDINCompanyDesignation
Suresh Vitthalrao Mane09649102Dellchem Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dellchem Healthcare Private Limited
Premium access

Shareholding and investment profile for Atesh Pandurang Bhange

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atesh Pandurang Bhange

Atesh Pandurang Bhange currently holds 1 directorship: Dellchem Healthcare Private Limited (Director, since 23 Jun 2022).

Atesh Pandurang Bhange was first appointed on 23 Jun 2022 as Director at Dellchem Healthcare Private Limited.

The current boards of Atesh Pandurang Bhange's companies include Suresh Vitthalrao Mane (Dellchem Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available